Calidi Biotherapeutics (CLDI) Net Cash Flow (QoQ) (2022 - 2025)
Calidi Biotherapeutics (CLDI) Net Cash Flow (QoQ) (2022 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Calidi Biotherapeutics | 1.88 Mn | -2.22 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -191.85% |
| Sep 30, 2025 | 196.47% |
| Jun 30, 2025 | -657.32% |
| Mar 31, 2025 | -87.37% |
| Dec 31, 2024 | 601.83% |
| Sep 30, 2024 | 472.11% |
| Jun 30, 2024 | 64.28% |
| Mar 31, 2024 | 89.94% |
| Dec 31, 2023 | -201.53% |
| Sep 30, 2023 | 595.08% |
| Jun 30, 2023 | 111.88% |
| Mar 31, 2023 | 93.97% |
| Dec 31, 2022 | 124.12% |
| Sep 30, 2022 | -335.16% |
| Jun 30, 2022 | 42.24% |